Sangeeta Bhatia, M.D., Ph.D.


Director, Laboratory for Multiscale Regenerative Technologies

Dr. Bhatia is a Howard Hughes Medical Institute Investigator and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS). She is a member of the Koch Institute for Integrative Cancer Research, the Ludwig Center for Molecular Oncology, and the Harvard Stem Cell Institute, a Senior member of the Broad Institute, and a Biomedical Engineer at the Brigham & Women's Hospital. Trained as both a physician and engineer, Bhatia’s laboratory is dedicated to leveraging miniaturization tools from the world of semiconductor manufacturing to impact human health. She has pioneered technologies for interfacing living cells with synthetic systems, enabling new applications in tissue regeneration, stem cell differentiation, medical diagnostics and drug delivery. Her multidisciplinary team has developed a broad and impactful range of inventions, including human micro livers which model human drug metabolism, liver disease, and interaction with pathogens, and a suite of communicating nanomaterials that can be used to interrogate, monitor and treat cancer and other diseases.  Her work has been profiled broadly such as in Scientific American, the Boston Globe, Popular Science, Forbes, PBS’s NOVA scienceNOW, the Economist and MSNBC.

More about Dr. Bhatia...

Dr. Bhatia trained at Brown, MIT, Harvard, and MGH. She is an elected member of the National Academy of Engineering, and a fellow of the Massachusetts Academy of Sciences, Biomedical Engineering Society, American Institute for Medical and Biological Engineering, and American Society for Clinical Investigation. She has been awarded the 2014 Lemelson-MIT Prize, the David and Lucile Packard Fellowship given to "the nation's most promising young professors in science and engineering," the NSF CAREER Award, the Y.C. Fung Young Investigator Award of the American Society of Mechanical Engineers, the Young Investigator Award of the American College of Clinical Pharmacology, the Brown Engineering Alumni Medal, and was named a Merkin Fellow of the Broad Institute. As a passionate mentor and advocate for diversity in science and engineering, she has been the recipient of the Harvard Medical School Diversity Award and the Harvard-MIT Thomas McMahon Mentoring Award. She co-authored the first undergraduate textbook on tissue engineering and is a frequent advisor to governmental organizations on nanobiotechnology, biomedical microsystems, and tissue engineering. She and her over 150 trainees have contributed to more than 40 issued or pending patents and launched 10 biotechnology companies with 70+ commercial products at the intersection of medicine and miniaturization. She has published more than 150 manuscripts which have been cited a total of over 14,500 times. Prior to her position at MIT, she held a tenured position at UCSD, and has worked in industry at Pfizer, Genetics Institute, ICI Pharmaceuticals, and Organogenesis. 


M.D., Harvard Medical School;
Ph.D., Biomedical Engineering, Massachusetts Institute of Technology;
Harvard-MIT Division of Health Sciences and Technology;
M.S., Mechanical Engineering, Massachusetts Institute of Technology;
B.S., Biomedical Engineering, Brown University;